Do NAD Supplements Work? What the Science Says

Are NAD boosters effective? We analyze the clinical data on NMN and NR to determine the proven benefits and limitations for human health.

NAD supplements reliably raise blood levels of NAD+ in humans, but the health benefits most people hope for remain modest and inconsistent across clinical trials. Nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR), the two most popular precursors sold as supplements, have shown promising results in animal studies for years. Translating those results into clear, measurable improvements in human health has proven far harder than the marketing suggests.

Why NAD+ Matters in the Body

NAD+ is a molecule involved in hundreds of chemical reactions inside your cells. It serves as a coenzyme in reactions that convert food into energy, and it also acts as a signal molecule that activates important enzymes including sirtuins, PARPs, and CD38. Sirtuins are especially relevant to the supplement conversation because they regulate glucose and fat metabolism, mitochondrial function, and inflammatory signaling. All sirtuin activity depends on NAD+ being available, which means that when NAD+ drops, these protective pathways slow down.

This is the core premise behind the entire NAD supplement industry: if falling NAD+ contributes to aging and disease, then boosting NAD+ back up should slow or reverse some of those effects. The logic is clean. The biology backing it up in test tubes and mice is strong. The question is whether swallowing a capsule actually delivers those benefits to a living human body.

How NAD+ Declines With Age

NAD+ levels drop as you get older, and researchers have spent the past decade trying to figure out why. A major part of the answer involves an enzyme called CD38. Its expression and activity increase with aging, and it actively chews through the body’s NAD+ supply. In mice, knocking out CD38 prevents the age-related drop in NAD+ and the mitochondrial problems that come with it.

The reason CD38 increases isn’t random. It appears to be driven by chronic, low-grade inflammation associated with aging. Senescent cells, which accumulate as you age and pump out inflammatory signals, promote the buildup of CD38-expressing immune cells in fat tissue and the liver. Removing senescent cells in mice or blocking their inflammatory secretions partially reverses the NAD+ decline. This matters for the supplement question because it raises an uncomfortable possibility: if the underlying problem is inflammation-driven enzyme activity that destroys NAD+, simply adding more precursor might be fighting a losing battle against an actively running drain.

What Actually Happens When You Swallow NMN or NR

Most people assume that NMN or NR pills get absorbed, travel through the blood, and top off NAD+ inside your cells. The actual journey is more complicated and less efficient. A 2025 study in Science Advances found that only a small portion of orally taken NMN or NR gets directly absorbed from the small intestine. Most of it is broken down by gut bacteria and converted into nicotinic acid, a much simpler molecule that then follows a different metabolic route to eventually produce NAD+.

The debate around how NMN enters cells has been running for years. One camp argues for a dedicated NMN transporter called Slc12a8, which has been identified in the mouse gut and shown to move NMN directly into cells. The other, more widely accepted view holds that NMN is first converted to NR outside the cell, then NR enters through its own set of transporters and gets rebuilt into NMN once inside. If the second view is correct, NMN supplements don’t have a meaningful absorption advantage over NR. Either way, the supplements do raise blood NAD+ levels; the question is whether the route and efficiency matter for the downstream health effects.

What Human Trials Actually Show

The human evidence falls into a frustrating pattern: NAD+ goes up in the blood, but the health outcomes most people care about are either small or statistically inconclusive. A 2025 systematic review and meta-analysis of NMN supplementation trials found no significant effect on body weight, BMI, fasting blood sugar, or hemoglobin A1c. Insulin resistance showed a mild trend toward improvement, but not one that reached statistical significance. Broad metabolic markers, in other words, barely budge.

There are a few brighter spots, though the studies are small. A trial in older men found that NMN supplementation improved walking speed and grip strength in one hand, without increasing muscle mass. A study in overweight or obese women with prediabetes found that NMN improved muscle insulin sensitivity measured by a precise laboratory technique, along with changes in insulin signaling at the molecular level. That’s a genuinely interesting finding, but it came from a single small trial, and the meta-analysis covering broader metabolic markers didn’t confirm the effect at a population level.

On the NR side, a crossover trial in middle-aged and older adults found that NR lowered systolic blood pressure by about 4 mmHg on average versus placebo, and reduced arterial stiffness. In a subgroup that started with above-normal blood pressure, the systolic drop was about 9 mmHg. A pilot trial in older adults with peripheral artery disease reported improvements in cerebrovascular response and cognitive performance after four weeks of NR, but with only eight participants and no placebo control, the study is a signpost rather than proof.

The honest summary is that oral NAD+ precursors are safe and they do raise NAD+ in blood, but their clinical effects in humans have been weaker than what animal studies predicted. That gap between animal promise and human reality is the central tension in this field right now.

The Safety Picture

One consistent finding across human trials is that NMN and NR are well-tolerated. A safety study testing NMN at 1,250 mg per day for four weeks found no clinically meaningful changes in blood work, urine, or body composition, and no serious adverse events. The meta-analysis of NMN trials echoed this, finding the supplements safe at studied doses.

There is, however, a theoretical concern worth taking seriously. Cancer cells are energy-hungry, and NAD+ fuels many of the metabolic pathways they depend on. Some researchers have raised the question of whether chronically elevating NAD+ could feed existing cancers or create a more favorable environment for new ones. No human trial has shown that NAD+ precursors increase cancer risk, but no trial has been large enough or long enough to rule it out either. People with active malignancies or a recent cancer history should talk to their oncologist before starting supplementation.

What About IV NAD+ Infusions

Walk past certain wellness clinics and you’ll see IV NAD+ drip sessions advertised for hundreds or even thousands of dollars. The science here is thin. Researchers still don’t fully understand what happens to NAD+ injected directly into the bloodstream. It’s likely broken down in the liver into nicotinamide and other fragments, and CD38-expressing immune cells in the blood may degrade it before it reaches target tissues. You’re paying a premium for a delivery method whose advantage over oral supplements hasn’t been demonstrated in clinical studies.

Exercise Raises NAD+ Through a Different Mechanism

If supplements take the approach of dumping in more raw material, exercise takes the approach of making the factory run better. Both aerobic and resistance exercise boost levels of NAMPT, the rate-limiting enzyme in your body’s main NAD+ recycling pathway. In one study, resistance training increased NAMPT protein in skeletal muscle by roughly 25 to 30 percent in both young and older people. A meta-analysis of the available studies estimated that exercise training roughly doubled NAMPT levels on average. Animal work supports this further, showing that regular exercise drives NAD+ production and activates sirtuins in skeletal muscle of aged rats.

This doesn’t mean exercise replaces supplements or vice versa, but it does put the supplement effect in context. Your body already has a built-in, free, well-proven way to upregulate NAD+ production. Whether combining exercise with supplementation produces additive benefits is something researchers haven’t nailed down yet.

Caloric Restriction and Fasting

Fasting is another natural way to shift the NAD+ balance. In mouse livers, a 24-hour fast increased NAD+ levels and boosted both NAMPT activity and SIRT1 expression. Caloric restriction more broadly activates sirtuins, particularly SIRT1 and SIRT3, with downstream effects on insulin response and antioxidant defense. These same sirtuin-mediated pathways appear to have beneficial effects on cardiovascular health.

The overlap between caloric restriction research and NAD+ supplement research is no coincidence. Both are working the same metabolic levers. The difference is that caloric restriction has decades of evidence behind it, while supplementation is still in early stages of human testing.

When You Take It Might Matter

NAD+ production in your body isn’t constant throughout the day. The NAMPT gene, which drives the main NAD+ recycling pathway, is under circadian control. Your molecular clock activates NAMPT transcription rhythmically, leading to daily fluctuations in intracellular NAD+ in the liver, muscle, heart, and fat tissue. Some clinical evidence suggests that taking NMN in the evening, particularly after 6:00 p.m., may be more effective at improving drowsiness and sleep quality.

The connection goes both ways: not only is NAD+ production driven by the clock, but NAD+ levels themselves influence the clock’s strength. In cardiomyocytes, dropping NAD+ weakened circadian rhythms, and adding NR restored them. If this translates to humans, chronically low NAD+ could contribute to the circadian disruptions common in older adults, and boosting NAD+ could help restore healthy rhythms. It’s an early-stage idea, but it’s one of the more interesting angles in current NAD+ research.

Quality Control Is a Real Problem

Even if you decide the evidence is promising enough to try supplementation, you face a practical obstacle: you can’t always trust what’s on the label. A study testing commercially available NMN supplements found that the actual amount of active ingredient deviated from what was claimed by as much as 28.6 percent over to 100 percent under, meaning some products contained literally none of the advertised compound. A separate analytical study examining eight commercial NMN supplements found substantial variation in the isomer composition of the products, including ingredients that were undeclared or inaccurately labeled.

NMN exists in two mirror-image forms, alpha and beta. The beta form is the biologically relevant one. If a supplement contains a significant amount of the alpha form or contains degradation products, you’re getting less usable material than the label implies. Governmental safety authorities generally verify the absence of prohibited substances, not the accuracy of what’s claimed to be inside. Third-party testing through services like NSF International or ConsumerLab is the closest thing to a quality guarantee available, and even that isn’t foolproof.

Formulation Differences and Combination Approaches

Supplement companies have been experimenting with delivery formats to improve absorption. An exploratory clinical study found that a liposomal form of NMN produced significantly higher blood NAD+ levels compared to standard NMN at the same 350 mg daily dose. Animal work with nanoparticle-based delivery has shown extended circulation time and improved tissue distribution, including to the brain and liver.

Combination strategies are another area of active experimentation. In mice, combining NMN with resveratrol increased NAD+ levels in heart tissue by about 1.6 times and in muscle by about 1.7 times compared to NMN alone. Whether this mouse-level synergy translates to humans, and whether higher tissue NAD+ levels translate to better clinical outcomes, are questions that haven’t been answered yet. The supplement industry has already moved ahead with combination products, but the science is still catching up.

Measuring Your Own NAD+ Levels

A growing number of companies offer at-home NAD+ testing, typically through a finger-prick blood sample. The technology behind this has some validation: a study showed that NAD+ measured from fingertip blood correlated well with standard venous blood draws, with results falling within about 15 percent of each other. The same study confirmed what researchers expected: NAD+ levels vary by age and gender in the general population.

What these tests can’t tell you is whether your NAD+ level is “too low” in any clinically meaningful sense, because there are no established reference ranges tied to health outcomes. Knowing your NAD+ went up after starting a supplement confirms the supplement did something biochemically, but it doesn’t tell you whether that biochemical change is producing any health benefit. Until clinical studies can connect specific NAD+ thresholds to specific outcomes, testing is more of a curiosity than a clinical tool.

NR Versus NMN

The NR-versus-NMN debate is one of the more heated corners of the longevity supplement world, and the honest answer is that current evidence doesn’t clearly favor one over the other. Both raise blood NAD+ levels. Both are converted into overlapping metabolites during digestion, with most oral NMN and NR being broken down by gut bacteria into nicotinic acid before being rebuilt into NAD+ through the liver. NR has slightly more published human trial data. NMN has more recent trials emerging. Neither has a head-to-head human comparison that settles the question of which produces better clinical outcomes.

From a regulatory standpoint, NR has generally had a smoother path in the United States as a supplement ingredient. NMN’s regulatory status has been more contested, with the FDA at one point questioning whether it could be sold as a dietary supplement because a drug company had begun investigating it as a pharmaceutical. This regulatory uncertainty hasn’t stopped companies from selling NMN, but it’s worth being aware of if you’re buying products and want some assurance about manufacturing standards.

The absorption debate described earlier applies mainly to NMN, since NR doesn’t need the same conversion step to enter cells. But given that both are largely broken down in the gut regardless, the theoretical transport advantage of one form over another may be less meaningful in practice than it seems on paper. Multiple NAD+ precursors including NR, NMN, nicotinic acid, and nicotinamide can all serve as raw material for NAD+ synthesis, and your body routes them through overlapping pathways. Choosing between NR and NMN at this stage is more a matter of price, availability, and personal comfort with the evidence base than a matter of clear scientific superiority.